ATARA BIOTHERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Earnings Per Share, Basic and Diluted of -$0.87 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-05
- ATARA BIOTHERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.87.
- ATARA BIOTHERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.96.
- ATARA BIOTHERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.90.
- ATARA BIOTHERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.91.
- ATARA BIOTHERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2021 was -$3.63.
- ATARA BIOTHERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2020 was -$4.15.
- ATARA BIOTHERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$5.67.
- ATARA BIOTHERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2018 was -$5.27.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.87 10-Q · filed 2022-05-05 | -$1.83 derived: net income ÷ weighted average shares · filed 2023-11-01 | -$2.74 derived: net income ÷ weighted average shares · filed 2023-11-01 | -$3.65 derived: net income ÷ weighted average shares · filed 2023-11-01 |
| 2021-12-31 | -$0.96 derived: net income ÷ weighted average shares · filed 2023-02-08 | -$1.86 derived: net income ÷ weighted average shares · filed 2023-02-08 | -$2.77 derived: net income ÷ weighted average shares · filed 2023-02-08 | -$3.63 10-K · filed 2022-02-28 |
| 2021-09-30 | -$0.90 10-Q · filed 2021-11-04 | -$1.81 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$2.67 10-Q · filed 2021-11-04 | -$3.62 derived: net income ÷ weighted average shares · filed 2023-02-08 |
| 2021-06-30 | -$0.91 10-Q · filed 2021-08-09 | -$1.77 10-Q · filed 2021-08-09 | -$2.71 derived: net income ÷ weighted average shares · filed 2023-02-08 | -$3.63 derived: net income ÷ weighted average shares · filed 2023-02-08 |
| 2021-03-31 | -$0.86 10-Q · filed 2022-05-05 | -$1.81 derived: net income ÷ weighted average shares · filed 2023-02-08 | -$2.72 derived: net income ÷ weighted average shares · filed 2023-02-08 | -$3.82 derived: net income ÷ weighted average shares · filed 2023-02-08 |
| 2020-12-31 | -$0.95 derived: net income ÷ weighted average shares · filed 2023-02-08 | -$1.87 derived: net income ÷ weighted average shares · filed 2023-02-08 | -$2.98 derived: net income ÷ weighted average shares · filed 2023-02-08 | -$4.15 10-K · filed 2022-02-28 |
| 2020-09-30 | -$0.92 10-Q · filed 2021-11-04 | -$2.04 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$3.21 10-Q · filed 2021-11-04 | -$4.53 derived: net income ÷ weighted average shares · filed 2022-02-28 |
| 2020-06-30 | -$1.14 10-Q · filed 2021-08-09 | -$2.34 10-Q · filed 2021-08-09 | -$3.68 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$4.99 derived: net income ÷ weighted average shares · filed 2022-02-28 |
| 2020-03-31 | -$1.20 10-Q · filed 2021-05-04 | -$2.56 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$3.86 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$5.42 derived: net income ÷ weighted average shares · filed 2022-02-28 |
| 2019-12-31 | -$1.36 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$2.67 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$4.24 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$5.67 10-K · filed 2022-02-28 |
| 2019-09-30 | -$1.31 10-Q · filed 2020-11-09 | -$2.89 derived: net income ÷ weighted average shares · filed 2020-11-09 | -$4.32 10-Q · filed 2020-11-09 | -$6.05 derived: net income ÷ weighted average shares · filed 2021-03-01 |
| 2019-06-30 | -$1.60 10-Q · filed 2020-08-05 | -$3.04 10-Q · filed 2020-08-05 | -$4.78 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$6.07 derived: net income ÷ weighted average shares · filed 2021-03-01 |
| 2019-03-31 | -$1.44 10-Q · filed 2020-05-06 | -$3.18 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$4.47 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$5.62 derived: net income ÷ weighted average shares · filed 2021-03-01 |
| 2018-12-31 | -$1.75 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$3.03 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$4.19 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$5.27 10-K · filed 2021-03-01 |
| 2018-09-30 | -$1.29 10-Q · filed 2019-11-07 | -$2.43 derived: net income ÷ weighted average shares · filed 2019-11-07 | -$3.49 10-Q · filed 2019-11-07 | -$4.65 derived: net income ÷ weighted average shares · filed 2020-02-27 |
| 2018-06-30 | -$1.15 10-Q · filed 2019-08-08 | -$2.20 10-Q · filed 2019-08-08 | -$3.34 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$4.38 derived: net income ÷ weighted average shares · filed 2020-02-27 |
| 2018-03-31 | -$1.05 10-Q · filed 2019-05-09 | -$2.19 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$3.21 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$4.16 derived: net income ÷ weighted average shares · filed 2020-02-27 |
| 2017-12-31 | -$1.15 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$2.17 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$3.11 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$4.00 10-K · filed 2020-02-27 |
| 2017-09-30 | -$1.02 derived: net income ÷ weighted average shares · filed 2018-11-06 | -$1.96 derived: net income ÷ weighted average shares · filed 2018-11-06 | -$2.84 derived: net income ÷ weighted average shares · filed 2018-11-06 | -$3.48 derived: net income ÷ weighted average shares · filed 2019-02-26 |
| 2017-06-30 | -$0.94 derived: net income ÷ weighted average shares · filed 2018-08-01 | -$1.82 derived: net income ÷ weighted average shares · filed 2018-08-01 | -$2.45 derived: net income ÷ weighted average shares · filed 2019-02-26 | -$3.33 derived: net income ÷ weighted average shares · filed 2019-02-26 |
| 2017-03-31 | -$0.88 derived: net income ÷ weighted average shares · filed 2018-05-08 | -$1.51 derived: net income ÷ weighted average shares · filed 2019-02-26 | -$2.39 derived: net income ÷ weighted average shares · filed 2019-02-26 | -$3.05 derived: net income ÷ weighted average shares · filed 2019-02-26 |
| 2016-12-31 | -$0.63 derived: net income ÷ weighted average shares · filed 2019-02-26 | -$1.51 derived: net income ÷ weighted average shares · filed 2019-02-26 | -$2.17 derived: net income ÷ weighted average shares · filed 2019-02-26 | -$2.75 10-K · filed 2019-02-26 |
| 2016-09-30 | -$0.88 derived: net income ÷ weighted average shares · filed 2017-11-09 | -$1.54 derived: net income ÷ weighted average shares · filed 2017-11-09 | -$2.12 derived: net income ÷ weighted average shares · filed 2017-11-09 | -$2.87 derived: net income ÷ weighted average shares · filed 2018-02-27 |
| 2016-06-30 | -$0.66 derived: net income ÷ weighted average shares · filed 2017-08-07 | -$1.24 derived: net income ÷ weighted average shares · filed 2017-08-07 | -$1.99 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$2.42 derived: net income ÷ weighted average shares · filed 2018-02-27 |
| 2016-03-31 | -$0.58 derived: net income ÷ weighted average shares · filed 2017-05-04 | -$1.33 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$1.76 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$2.37 derived: net income ÷ weighted average shares · filed 2018-02-27 |
| 2015-12-31 | -$0.75 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$1.18 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$1.79 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$2.24 derived: net income ÷ weighted average shares · filed 2018-02-27 |
| 2015-09-30 | -$0.43 derived: net income ÷ weighted average shares · filed 2016-11-04 | -$1.03 derived: net income ÷ weighted average shares · filed 2016-11-04 | -$1.46 derived: net income ÷ weighted average shares · filed 2016-11-04 | $0.05 derived: net income ÷ weighted average shares · filed 2017-03-09 |
| 2015-06-30 | -$0.62 derived: net income ÷ weighted average shares · filed 2016-08-08 | -$1.04 derived: net income ÷ weighted average shares · filed 2016-08-08 | $0.03 derived: net income ÷ weighted average shares · filed 2017-03-09 | $0.06 derived: net income ÷ weighted average shares · filed 2017-03-09 |
| 2015-03-31 | -$0.42 derived: net income ÷ weighted average shares · filed 2016-05-06 | $0.01 derived: net income ÷ weighted average shares · filed 2017-03-09 | $0.03 derived: net income ÷ weighted average shares · filed 2017-03-09 | $0.05 derived: net income ÷ weighted average shares · filed 2017-03-09 |
| 2014-12-31 | $0.00 derived: net income ÷ weighted average shares · filed 2017-03-09 | $0.01 derived: net income ÷ weighted average shares · filed 2017-03-09 | $0.02 derived: net income ÷ weighted average shares · filed 2017-03-09 | -$5.62 derived: net income ÷ weighted average shares · filed 2017-03-09 |
| 2014-09-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2015-11-06 | -$0.01 derived: net income ÷ weighted average shares · filed 2015-11-06 | -$0.01 derived: net income ÷ weighted average shares · filed 2015-11-06 | -$0.06 derived: net income ÷ weighted average shares · filed 2016-03-04 |
| 2014-06-30 | -$3.37 derived: net income ÷ weighted average shares · filed 2015-08-07 | -$8.89 derived: net income ÷ weighted average shares · filed 2015-08-07 | -$12.15 derived: net income ÷ weighted average shares · filed 2016-03-04 | -$14.99 derived: net income ÷ weighted average shares · filed 2016-03-04 |
| 2014-03-31 | -$5.58 derived: net income ÷ weighted average shares · filed 2015-05-11 | -$8.86 derived: net income ÷ weighted average shares · filed 2016-03-04 | -$11.69 derived: net income ÷ weighted average shares · filed 2016-03-04 | |
| 2013-12-31 | -$3.14 derived: net income ÷ weighted average shares · filed 2016-03-04 | -$5.78 derived: net income ÷ weighted average shares · filed 2016-03-04 | -$9.08 derived: net income ÷ weighted average shares · filed 2016-03-04 | |
| 2013-09-30 | -$2.59 derived: net income ÷ weighted average shares · filed 2014-11-12 | -$5.73 derived: net income ÷ weighted average shares · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |